Catalent to Present at West Coast Meeting of Parenteral Drug Association (PDA)

Two members of Catalent's Respiratory, Analytical and Biotechnology Group will participate in the Parenteral Drug Association West Coast Chapter’s panel discussion titled “Challenges and Best Practices in Extractable and Leachables.”
By: Dan Dunlop
 
Jan. 19, 2009 - PRLog -- Research Triangle Park, N.C. – Patty Kiang, Ph.D., Catalent’s Account Director for Analytical & Biotech Services for its Northern C.A./Pacific Northwest territory, and Tom Feinberg, Ph.D., Catalent’s Director, Structural Chemistry will both participate in the Parenteral Drug Association (PDA) West Coast Chapter’s panel discussion titled “Challenges and Best Practices in Extractable and Leachables.” The panel is part of the Chapter’s 2009 Professional Dinner Meeting Series.  

Kiang, who has served in the past as a faculty member of the Parenteral Drug Association’s (PDA) Training and Research Institute, will moderate the evening’s discussion. Feinberg, a member of the PQRI Leachables & Extractables Working Group, is scheduled to deliver a presentation titled: “Future of Extractables and Leachables Regulatory Expectations - A PQRI Process Update.” Both Kiang and Feinberg work within Catalent’s Respiratory, Analytical and Biotechnology Group, with sites in Research Triangle Park, N.C., San Diego, C.A. and Middleton, W.I.

The PDA event will be held January 22 at 6pm in South San Francisco. Additional information about the 2009 Dinner Meeting Series and this panel discussion can be found at http://www.wccpda.org.

About Catalent
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,500 at more than 30 facilities worldwide and generates more than $1.8 billion of annual revenue. For more information, visit http://www.catalent.com.

# # #

Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries. Www.catalent.com.
End
Source:Dan Dunlop
Email:***@jenningsco.com Email Verified
Zip:27514
Tags:Biotech, Catalent, Leachables, Extractables, Tom Feinberg, Patty Kiang, Analytical Services, Structural Chemistry, Pda
Industry:Biotech, Health, Science
Location:Chapel Hill - North Carolina - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Catalent Pharma Solutions News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share